Innovative approaches in wound healing: Trajectory and advances

Artificial Cells, Nanomedicine and Biotechnology

Volumn 41, Issue 3, 2013, Pages 202-212

  Singh, Manju Rawat ^a   Saraf, Shailendra ^a   Vyas, Amber ^a   Jain, Vishal ^a   Singh, Deependra ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Acute; Chronic wounds; Dressings; Skin grafts; Wound; Wound healing; Wounds

Indexed keywords

ACUTE; CHRONIC WOUNDS; DRESSINGS; SKIN GRAFT; WOUND; WOUND HEALING; WOUNDS;

DRUG DELIVERY;

PILES;

ANTIINFECTIVE AGENT; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BECAPLERMIN; CADEXOMER IODINE; CHLORHEXIDINE; EPIGALLOCATECHIN GALLATE; FREE RADICAL; GENTAMICIN; GOLD NANOPARTICLE; GROWTH FACTOR; HYDROGEN PEROXIDE; INOTROPIC AGENT; IODINE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTENIDINE; POLYMER; POVIDONE IODINE; RECOMBINANT GROWTH FACTOR; REPIFERMIN; SERRATIOPEPTIDASE; SILVER; SILVER NANOPARTICLE; STEROID;

ABRASION; AGING; APOPTOSIS; ARTICLE; BITE WOUND; BURN; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC WOUND; DEBRIDEMENT; DECUBITUS; DIABETES MELLITUS; DIABETIC FOOT; DRUG DELIVERY SYSTEM; EDEMA; EXTRACELLULAR MATRIX; EXUDATE; FIBROBLAST; FILM; FOOT ULCER; GENE THERAPY; GENE TRANSFER; GRANULATION TISSUE; HEMOSTASIS; HONEY; HUMAN; HYDROCOLLOID; HYDROGEL DRESSING; INFECTION CONTROL; INFLAMMATION; ISCHEMIC WOUND; MOISTURE; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; PUNCTURE WOUND; RHEUMATOID ARTHRITIS; SHOCK; SKIN GRAFT; SKIN INJURY; STEM CELL TRANSPLANTATION; ULCER; VEIN INSUFFICIENCY; WOUND; WOUND CARE; WOUND CONTRACTION; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

ANTI-INFECTIVE AGENTS; BANDAGES; DEBRIDEMENT; DRUG DELIVERY SYSTEMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; POLYMERS; SKIN TRANSPLANTATION; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84878488525     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2012.716065     Document Type: Article

References (96)

1. Albert M. 2008. The Role of Hyberbaric Oxygen Th erapy in Wound Healing. Wound Care Canada. 6: 60-62.
2. Andree C, Swain WF, Page CP, Macklin MD, Slama J, Hatzis D, et al. 1994. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA. 91: 12188-12192.
3. Avicenna. 1783. De Ulceribus, Liber IV. In: Underwood M. Ed. A Treatise upon Ulcers of the Legs. London: Matthews, pp. 1736-1820.
4. Badiavas E, Abedi M, Butmarc J, Falanga V, Quesenberry PJ. 2003. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 196: 245-250.
5. Bailey AJ, Bazin S, Sims TJ, Le Lous M, Nicoletis C, Delaunay A. 1975. Collagen polymorphism in experimental granulation tissue. Biochim Biophys Acta. 405: 412.
6. Baldwin G, Colbourne M. 1999. Puncture wounds. Pediat Rev. 20: 21-23.
7. Bowler PG, Duerden BI, Armstrong DG. 2001. Wound microbiology and associated approaches to wound management. Clin Microbio Rev. 14: 244-269.
8. Bruncardi FC. 2005. Schwartz ' s Principles of Surgery. 8th ed. Schwartz, New York: McGraw-Hill.
9. Cha J, Falanga V. 2007. Stem cells in cutaneous wound healing. Clin Dermat. 25: 73-78.
10. Clark RA, Folkvord JM, Hart CE, Murray MJ, McPherson JM. 1989. Platelet isoforms of platelet-derived growth factor stimulate fi broblasts to contract collagen matrices. J Clin Invest. 84: 1036.
11. Clark RA, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. 1982. Fibronectin and fi brin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol. 79: 264-269.
12. Clark RAF. 1996. Wound repair overview and general considerations. In: Te Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, pp. 3-10.
13. Cohen MA, Eaglstein WH. 2001. Recombinant human platelet-derived growth factor gel speeds healing of acute full-thickness punch biopsy wounds. J Am Acad Derm. 45: 857-862.
14. Collier M. 2006. Understanding the principles of wound management. J Wound Care. 15: S7-S10.
15. Davie EW, Fujikawa K, Legaz ME, Kato H. 1975. Role of proteases in blood coagulation. Cold Spring Harbor Confer Cell Proliferation. 2: 65-77.
16. De Santi L. 2005. Pathophysiology and current management of burn injury. Adv Skin Wound Care. 18: 323-332.
17. Desia H. 1997. Ageing and wounds part 2. J Wound Care. 6: 237-239.
18. Desmoulière A, Gabbiani G. 1996. The role of the myofbroblast in wound healing and fi brocontractive diseases. In: Clark RAF. Ed. Te Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, pp. 391-402.
19. Diegelmann RF, Evans MC. 2004. Wound healing: An overview of acute, fi brotic and delayed healing. Front Biosci. 9: 283-289.
20. Eaglstein WH. 2001. Moist wound healing with occlusive dressings: A clinical focus. Dermatol Surg. 27: 175-181.
21. Embil JM, Papp K, Sibbald G, Tousignant J, Smiell JM, Wong B, et al. 2000. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: An openlabel clinical evaluation of effi cacy. Wound Rep Reg. 8: 162-168.
22. Falanga V, Grinnell F, Gilchrest B, Maddox YT, Moshell A. 1994. Workshop on the pathogenesis of chronic wounds. J Invest Dermat. 102: 125-127.
23. Falanga V, Sabolinski M. 1999. Bilayered living skin construct (APLIGRAF →) accelerates complete closure of hard-to-heal venous ulcers. Wound Rep Regen. 7: 201-207.
24. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. 1995. Interstitial collagenase is required for angiogenesis in vitro. Develop Biol. 162: 499-510.
25. Friess W. 1988. Biomaterial for drug delivery. Eur J Pharm Biopharm. 45: 113-136.
26. Galen C. 1976. Ad scripti libri. Venice: Vincentium Valgressium. In: Dodd H. Ed. Te Pathology and Surgery of the Veins of the Lower Limb. London: Churchill Livingstone, pp. 4-14.
27. Garlick JA, Taichman LB. 1994. Fate of human keratinocytes during reepithelialization in an organotypic culture model. Lab invest ; J Tech Meth Path. 70: 916-924.
28. Gay J. 1868. On Varicose Disease of the Lower Extremities and Its Allied Disorders. Lettsomian Lectures of 1867. London: Churchill.
29. Gharaee-Kermani M, Phan SH. 2001. Role of cytokines and cytokine therapy in wound healing and fi brotic diseases. Curr Pharm Des. 7: 1083-103.
30. Gilbertson DG, Duf ME, West JW, Kelly JD, Sheppard PO, Hofstrand PD, et al. 2001. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF-a and b receptor. J Biol Chem. 276: 27406-27414.
31. Hendi A. 2011. Silver nanoparticles mediate diff erential responses in some of liver and kidney functions during skin wound healing. J King Saud Univ (Science). 23: 47-52.
32. Herndon DN, Nguten TT, Gilphin DA. 1993. Growth Factors Local and Systemic. Arch Surg. 128: 1227-1233.
33. Hippocrates. 1849. De Ulcerbis, De Carnabus. In: Adams F. Ed. Te Genuine Works of Hippocrates. London: Sydenham Society. pp. 391-423.
34. H ü bner G, Brauchle M, Smola H, Madlener M, F ä ssler R, Werner S. 1996. Diff erential regulation of pro-infl ammatory cytokines during wound healing. Cytokine. 8: 548-566.
35. Hunter J. 1837. Observations on the infammation of the internal coats of veins. In: Hunter J, Palmer JI. Eds. Te Works of John Hunter. London: Longman, Rees, Orme & Longman, pp. 581-586.
36. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R. 1995. Slowing of wound healing by psychological stress. Lancet. 346: 1194-1196.
37. Klasen HJ. 2000. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. J Int Soc Burn Inj. 26 : 131-138.
38. Lansdown AB, Silver G. 2002a. Silver I: Its antibacterial properties and mechanism of action. J Wound Care 11: 173-177.
39. Lansdown AB, Silver G. 2002b. Silver II: Toxicity in mammals and how its products aid wound repair. J Wound Care. 11: 125-130.
40. Lanza R. 2004. Handbook of Stem Cells. Boston, MA: Academic Press, pp. 731-736.
41. Lawrence WT. 1998. Physiology of the acute wounds. Clin Plast Surg. 25: 321-328.
42. Lazarus GS, Cooper DM, Knighton DR. 1994. Defi nitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 130: 489-493.
43. Leaper D. 1987. Antiseptic solutions ples. J Wound Care. 1: 27-30.
44. Leu JG, Chen SA, Chen HM, Wu WM, Hung CF, Yao YD, et al. 2012. The eff ects of gold nanoparticles in wound healing with antioxidant epigallocatechin gallate and 〈 -lipoic acid. Nanomedicine. 8 : 767-775.
45. Majno G, Joris I. 1996. Cells, tissues, and disease. In: Majno G, Joris I. Eds. Principles of General Pathology. Cambridge, MA: Blackwell Science Inc., pp. 230-238.
46. Margolis DJ. 1995. Defi nition of a pressure ulcer. Adv Wound Care. 8: 8-10.
47. Martin P. 1997. Wound healing-aiming for perfect skin regeneration. Science. 276: 75-81.
48. Masre SF, Yip GW, Sirajudeen KNS, Ghazali FC. 2012. Quantitative analysis of sulphated glycosaminoglycans content of Malaysian sea cucumber Stichopus hermanni and Stichopus vastus. Nat Prod Res. 26: 684-689.
49. McCarthy J.G. 2006 Current Th erapy in Plastic Surgery 1 st ed. Philadelphia, PA Saunders.
50. McCarthy JG. 2006. Current Th erapy in Plastic Surgery. 1 st ed. Philadelphia, PA: Saunders. Mertz PM, Eaglstein WH. 1984. The eff ect of a semiocclusive dressing on the microbial population in superfi cial wounds. Arch Surg. 119: 287-289.
51. Mignatti P, Rifkin DB, Welgus HG, Parks WC. 1996. Proteinases and tissue remodeling. In: Clark RAF. Ed. The Molecular and Cellular Biology of Wound Repair. Plenum Press: New York, pp. 427-474.
52. Monaco JL, Lawrence WT. 2003. Acute wound healing: An overview. Clin Plast Surg. 30: 1-12.
53. Montesano R, Orci L. 1988. Transforming growth factor beta stimulates collagen-matrix contraction by fi broblasts: Implications for wound healing. Proc Natl Acad Sci USA. 85: 4894-4897.
54. Niwa Y. 1987. The ratio of lipidperoxides to superoxide dismutase activity in the skin lesions of patients with severe skin diseases: An acute prognostic indicator. Life Sci. 40: 921-927.
55. Orgill D, Demling RH. 1988. Current concepts and approaches to wound healing. Crit Care Med. 16: 899-908.
56. Phillips SJ. 2000. Physiology of wound healing and surgical wound. ASAIO J. 46: S2-S5.
57. Phillips TJ, Al-Amoudi HO, Leverkus M, Park HY. 1998. Eff ect of chronic wound fl uid on fi broblasts. J Wound Care. 7: 527-532.
58. Provencher MT, Allen LR, Gladden MJ. 2006. The underestimation of a glass injury to the hand. Am J Orthop. 35: 91-94.
59. Reed BR, Clark RAF. 1985. Cutaneous tissue repair: Practical implications of current knowledge-II. J Am Acad Dermatol. 13: 919-941.
60. Reibman J, Meixler S, Lee TC, Gold LI, Cronstein BN, Haines KA, et al. 1991. Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci. 88: 6805-6809.
61. Reiss MJ, Han YP, Garner WL. 2009. Alpha1-antichymotrypsin activity correlates with and may modulate matrix metalloproteinase-9 in human acute wounds. Wound Rep Reg. 17: 418-426.
62. Richard JL, Parer-Richard C, Daures JP, Clouet S, Vannereau D, Bringer J, et al. 1995. Eff ect of topical basic fi broblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot randomized, doubleblind, placebo-controlled study. Diabetes Care. 18: 64-69.
63. Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, Parish LC, Jensen JL, et al. 2001. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Rep Reg. 9: 347-352.
64. Rochat A, Kobayashi K, Barrandon Y. 1994. Location of stem cells of human hair follicles by clonal analysis. Cell. 76: 1063-1073.
65. Ruszczak Z, Friess W. 2003. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Del Rev. 55: 1679-1698.
66. Ryan GB, Manjo G. 1987. Acute infl ammation - a review. Am J Pathol. 86: 183-276.
67. Saap LJ, Falanga V. 2002. Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Rep Reg. 10: 354-359.
68. Sabine AE, Tomas K, Jefrey MD. 2007. Gene therapy and wound healing. Clin Dermatol. 25: 79-92.
69. Schiro JA, Chan BM, Roswit WT, Kassner PD, Pentland AP. 1991. Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell 67: 403-410.
70. Scholz A. 1993. Historical aspects. In: Westerhof W. Ed. Leg Ulcer:Diagnosis and Treatment. Amsterdam: Elsevier, pp. 5-15.
71. Seymour DE, Da Costa N, Hodgson M, Dow J. 1972. Adhesive materials, UK patent #12800631.
72. Shackelford DP, Fackler E, Hofman MK, Atkinson S. 2002. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation. Am J Obs Gyn. 186: 701-704.
73. Sheridan RI, Tompkins RG. 1990. Skin substitutes in burns. Burns. 25: 97-103.
74. Singer AJ, Clark RA. 1999. Cutaneous wound healing. N Engl J Med. 341: 738-746.
75. Singh D, Dixit VK, Saraf S, Saraf S. 2009. Formulation optimization of serratiopeptidase-loaded PLGA microspheres using selected variables. PDA J Pharm Sci Technol. 63: 103-112.
76. Singh D, Saraf S, Dixit VK, Saraf S. 2008. Formulation optimization of gentamicin loaded Eudragit RS100 microspheres using factorial design study. Biol Pharm Bull 31: 662-667.
77. Singh D, Singh M, Dixit VK, Saraf S, Saraf S. 2010a. Optimization and characterization of gentamicin loaded chitosan microspheres for eff ective wound healing. Ind J Pharm Educ Res. 44: 171-182.
78. Singh D, Singh M, Dixit VK, Saraf S, Saraf S. 2010b. Eff ect of formulation variables on preparation of GM loaded PLGA microspheres. Indian Drugs 47: 35-44.
79. Singh D, Singh M, Dixit VK, Saraf S, Saraf S. 2010c. Formulation optimization of metronidazole loaded chitosan microspheres for wound management by 3-Factor, 3-level box-behnken design. Micro Nanosystems. 2: 70-77.
80. Singh D, Singh M. 2011. Development of delivery cargoes for debriding enzymes eff ective in wound healing. Trend Appl Sci Res. 6: 863-876.
81. Singh D, Singh MR. 2012. Development of antibiotic and debriding enzyme loaded PLGA microspheres entrapped in PVA-Gelatin hydrogel for complete wound management. Artif Cells Blood Substitutes Biotechnol. Epub ahead, 1-9.
82. Singh M, Singh D, Saraf S, Saraf S. 2011. Infl uence of selected formulation variables on the preparation of peptide loaded lipospheres. Trend Med Res. 6: 101-115.
83. Stadelmann WK, Digenis AG, Tobin GR. 1998. Impediments to wound healing. Am J Surg. 176: 39-44.
84. Stefanopoulos PK, Tarantzopoulou AD. 2005. Facial bite wounds: Management update. J Oral Maxillofac Surg. 34: 464-472.
85. Th eden JCA. 1782. Neue Bermerkungen und Erfahrungen zue Beriecherung der Wundarzenykunst und Arzenygelahrteit, vol. 2. Berlin: Nicolai.
86. Th ompson P. 1998. The microbiology of wounds. J Wound Care. 7 : 477-478.
87. Trott A. 1997. Wounds and Lacerations: Emergency Care and Closure. 2nd ed. St. Louis, MO: Mosby.
88. Tsang MW, Wong WK, Hung CS, Lai KM, Tang W, Cheung EY, et al. 2003. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care. 26: 1856-1861.
89. Viljanto J. 1964. A sponge implantation method for testing connective tissue regeneration in surgical patients. Acta Chir Scand. 333: 1-101.
90. Wakefi eld TW, Greenfeld LJ, Mulholland MW, Oldham KT, Zelenock GB, Lillemoe KD. 2001. Hemostasis in Surgery: Scientifc Principals and Practice. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, pp. 275-281.
91. Welch MP, Odland GF, Clark RA. 1990. Temporal relationships of F-actin bundle formation, collagen and fi bronectin matrix assembly, and fi bronectin receptor expression to wound contraction. J Cell Biol. 110: 133-145.
92. Winter GD. 1962. Formation of the scab and the rate of epithelization of superfi cial wounds in the skin of the young domestic pig. Nature. 193: 293-294.
93. Wiseman R. 1676. Several Chirurgical Treatises. London: Wilthoe & Knapton.
94. Woodley DT, Yamauchi M, Wynn KC, Mechanic G, Briggaman RA. 1991. Collagen telopeptides (cross-linking sites) play a role in collagen gel lattice contraction. J Invest Dermatol. 97: 580-585.
95. Wysocki AB. 1999. Skin anatomy, physiology, and pathophysiology. Nurs Clin North Am. 34: 777-797.
96. Zhou LH, Nahm WK, Badiavas E, Yuft T, Falanga V. 2002. Slow release iodine preparation and wound healing: In vitro eff ects consistent with lack of in vivo toxicity in human chronic wounds. Brit J Dermat. 146: 365-374.